Eli Lilly and Co (LLY)
770.00
-17.02
(-2.16%)
USD |
NYSE |
May 16, 16:00
771.92
+1.92
(+0.25%)
After-Hours: 16:35
Eli Lilly Cash from Operations (Quarterly): 1.166B for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 1.166B |
December 31, 2023 | -311.90M |
September 30, 2023 | 2.190B |
June 30, 2023 | 631.90M |
March 31, 2023 | 1.731B |
December 31, 2022 | 1.663B |
September 30, 2022 | 2.217B |
June 30, 2022 | 1.183B |
March 31, 2022 | 2.523B |
December 31, 2021 | 2.262B |
September 30, 2021 | 1.631B |
June 30, 2021 | 1.776B |
March 31, 2021 | 1.697B |
December 31, 2020 | 1.815B |
September 30, 2020 | 1.807B |
June 30, 2020 | 2.495B |
March 31, 2020 | 382.40M |
December 31, 2019 | 1.964B |
September 30, 2019 | 1.510B |
June 30, 2019 | 1.052B |
March 31, 2019 | 311.30M |
December 31, 2018 | 1.449B |
September 30, 2018 | 2.122B |
June 30, 2018 | 1.518B |
March 31, 2018 | 436.50M |
Date | Value |
---|---|
December 31, 2017 | 1.744B |
September 30, 2017 | 1.881B |
June 30, 2017 | 1.651B |
March 31, 2017 | 339.90M |
December 31, 2016 | 2.006B |
September 30, 2016 | 1.662B |
June 30, 2016 | 1.402B |
March 31, 2016 | -219.10M |
December 31, 2015 | 996.10M |
September 30, 2015 | 1.105B |
June 30, 2015 | 948.60M |
March 31, 2015 | -84.80M |
December 31, 2014 | 1.441B |
September 30, 2014 | 1.691B |
June 30, 2014 | 1.054B |
March 31, 2014 | 272.30M |
December 31, 2013 | 1.727B |
September 30, 2013 | 1.992B |
June 30, 2013 | 1.637B |
March 31, 2013 | 379.40M |
December 31, 2012 | 1.602B |
September 30, 2012 | 1.544B |
June 30, 2012 | 1.306B |
March 31, 2012 | 852.50M |
December 31, 2011 | 1.945B |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-311.90M
Minimum
Dec 2023
2.523B
Maximum
Mar 2022
1.569B
Average
1.714B
Median
Cash from Operations (Quarterly) Benchmarks
Amgen Inc | 689.00M |
Biogen Inc | 553.20M |
Johnson & Johnson | 3.657B |
Vertex Pharmaceuticals Inc | 1.307B |
Viking Therapeutics Inc | -6.134M |
Cash from Operations (Quarterly) Related Metrics
Cash from Investing (Quarterly) | -1.178B |
Cash from Financing (Quarterly) | -311.30M |
Free Cash Flow | -3.896B |
Free Cash Flow Per Share (Quarterly) | 0.0921 |
Free Cash Flow to Equity (Quarterly) | -902.90M |
Free Cash Flow to Firm (Quarterly) | 201.53M |
Free Cash Flow Yield | -0.56% |